Canada’s Opportunity to Bridge Domestic and Global Action to End Cervical Cancer

Outcomes from a CanWaCH and Results Canada Roundtable on Cervical Cancer Prevention

Cervical cancer is the fourth leading cause of cancer-related deaths among women worldwide despite the availability of highly effective preventive measures, including the human papillomavirus (HPV) vaccine.

To mark International Women’s Day 2026, CanWaCH and Results Canada brought together advocates and policy leads from the Canadian Partnership Against Cancer, CITAM Plus (a Zambia-based organization), Grand Challenges Canada, Action Canada, and the Canadian Physicians for Aid and Relief (including the Country Manager for Ethiopia), Global Affairs Canada and Health Canada senior officials, representatives from Unitaid, Gavi and the Global Financing Facility, and academics from the University of Ottawa’s School of Epidemiology and Public Health and Queen’s University School of Medicine, to initiate dialogue.

Based on their respective expertise, the participants discussed challenges and solutions, which highlighted the similarities between global contexts in which Canada has invested to help eliminate cervical cancer, and domestic efforts.

This document summarizes this discussion and elaborates on the recommendations that were raised to ensure Canada continues to demonstrate leadership and adopts a multi-sectoral approach to cervical cancer, bridging local and global solutions to address common challenges.